Allianz Asset Management GmbH decreased its position in Ventas, Inc. (NYSE:VTR – Free Report) by 6.9% during the 3rd quarter, Holdings Channel.com reports. The fund owned 678,773 shares of the real estate investment trust’s stock after selling 50,575 shares during the quarter. Allianz Asset Management GmbH’s holdings in Ventas were worth $47,507,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VTR. Cloud Capital Management LLC acquired a new position in Ventas during the 3rd quarter valued at about $25,000. True Wealth Design LLC raised its stake in shares of Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 180 shares during the period. ORG Partners LLC boosted its stake in Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares during the last quarter. Finally, Ameritas Advisory Services LLC acquired a new stake in Ventas during the 2nd quarter worth $33,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Ventas Stock Down 0.0%
Shares of VTR stock opened at $77.67 on Thursday. Ventas, Inc. has a 12-month low of $58.72 and a 12-month high of $81.89. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The firm has a fifty day moving average of $78.09 and a 200-day moving average of $73.04. The company has a market capitalization of $36.48 billion, a price-to-earnings ratio of 149.37, a P/E/G ratio of 1.94 and a beta of 0.77.
Ventas Dividend Announcement
Insider Transactions at Ventas
In other news, CEO Peter J. Bulgarelli sold 2,771 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $80.01, for a total transaction of $221,707.71. Following the completion of the transaction, the chief executive officer directly owned 108,717 shares of the company’s stock, valued at $8,698,447.17. This trade represents a 2.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert F. Probst sold 33,591 shares of Ventas stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the completion of the sale, the chief financial officer owned 168,364 shares in the company, valued at $12,925,304.28. This trade represents a 16.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 130,499 shares of company stock valued at $10,155,831 over the last three months. Company insiders own 0.80% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on VTR. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 price target on shares of Ventas in a research note on Monday, December 15th. KeyCorp increased their target price on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Cantor Fitzgerald restated an “overweight” rating and set a $93.00 target price on shares of Ventas in a research report on Monday, January 5th. Wells Fargo & Company increased their price target on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Finally, Scotiabank boosted their price objective on shares of Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $81.63.
View Our Latest Analysis on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
